EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old. (2022)
Attributed to:
Cutaneous Immunology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/all.15030
PubMed Identifier: 34324716
Publication URI: http://europepmc.org/abstract/MED/34324716
Type: Journal Article/Review
Volume: 77
Parent Publication: Allergy
Issue: 1
ISSN: 0105-4538